Peter Radovich
2023
In 2023, Peter Radovich earned a total compensation of $2.4M as President and Chief Operating Officer at Mirum Pharmaceuticals, a 52% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $363,600 |
---|---|
Option Awards | $977,107 |
Salary | $505,000 |
Stock Awards | $508,577 |
Other | $13,200 |
Total | $2,367,484 |
Radovich received $977.1K in option awards, accounting for 41% of the total pay in 2023.
Radovich also received $363.6K in non-equity incentive plan, $505K in salary, $508.6K in stock awards and $13.2K in other compensation.
Rankings
In 2023, Peter Radovich's compensation ranked 427th out of 2,983 executives tracked by ExecPay. In other words, Radovich earned more than 85.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 427 | 86th |
Manufacturing | 242 | 85th |
Chemicals And Allied Products | 171 | 81st |
Drugs | 168 | 81st |
Pharmaceutical Preparations | 106 | 83rd |
Radovich's colleagues
We found two more compensation records of executives who worked with Peter Radovich at Mirum Pharmaceuticals in 2023.
News
Mirum Pharmaceuticals CEO Christopher Peetz's 2023 pay jumps 47% to $6.5M
April 23, 2024
Mirum Pharmaceuticals CEO Christopher Peetz's 2022 pay rises 7% to $4.4M
May 1, 2023
Mirum Pharmaceuticals CEO Christopher Peetz's 2021 pay jumps 38% to $4.1M
April 22, 2022
Mirum Pharmaceuticals CEO Christopher Peetz's 2020 pay falls 52% to $3M
April 14, 2021